Peripheral Stent Implant Market
Peripheral Stent Implant Market Study by Bare Metal Stents, Covered Stents, and Drug Eluting Stents for Hospitals and Ambulatory Surgical Centers/Outpatient from 2024 to 2034
Analysis of Peripheral Stent Implant Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Peripheral Stent Implant Market Outlook (2024 to 2034)
The global peripheral stent implant market is calculated to reach a valuation of US$ 4.11 billion in 2024 and climb to US$ 7.76 billion by the end of 2034. This latest research study by skilled analysts at Fact.MR states that demand for peripheral stent implants is forecasted to rise at 6.6% CAGR from 2024 to 2034.
Peripheral artery disease (PAD) is a disorder where plaque builds up in the arteries supplying blood to the brain, kidney, intestines, and limbs as well as the belly, and it is treated with a peripheral stent. Stents are artificial tubular mesh constructions that are utilized to increase vessel potency in either native or grafted vasculature, whether they are peripheral, intravascular, or endovascular.
After implantation, a stent is intended to offer mechanical radial support. A balloon or self-expanding mechanism is used to expand the stent once it has been placed in the desired location. The market is exhibiting steady growth due increasing prevalence of peripheral artery disease (PAD) and the requirement for such treatment for the aging population.
Key Market Growth Drivers
- Growing demand for minimally invasive procedures and the increasing prevalence of peripheral artery disease are key factors contributing to the peripheral stent implant market growth. Minimally invasive procedures help improve the quality of life while lowering morbidity and mortality.
- There are more options for treating PAD due to recent advancements in radiation, gene therapy, imaging material and device technologies, and implementation. Drug-eluting technology, excisional atherectomy, and balloon angioplasty are examples of percutaneous intervention techniques.
- Because peripheral stents are less intrusive and more affordable and need a shorter recovery period than surgical revascularization, they are a favored choice for cases with acute recoil and stenosis.
- Key market players are focusing on the development of novel absorbable stents and peripheral local drug delivery such as antiproliferative and antithrombotic medication for the treatment and prevention of restenosis with less adverse effects or complications, such as thrombosis and bleeding.
| Report Attribute | Detail |
|---|---|
| Peripheral Stent Implant Market Size (2024E) | US$ 4.11 Billion |
| Forecasted Market Value (2034F) | US$ 7.76 Billion |
| Global Market Growth Rate (2024 to 2034) | 6.6% CAGR |
| North America Market Share (2024E) | 51.7% |
| East Asia Market Value (2024E) | US$ 378 Million |
| Sales of Bare Metal Stents (2034F) | US$ 5.88 Billion |
| Sales of Fem-Pop Artery Stents (2034F) | US$ 2 Billion |
| Hospitals Segment Market Share (2034F) | US$ 4.38 Billion |
| Key Companies Profiled | Biotronik SE & Co. KG; W. L. Gore & Associates Inc.; Abbott Laboratories; Cook Medical, Inc.; B. Braun Melsungen AG; Medtronic Plc.; Terumo Medical; Microport Scientific Corporation; Boston Scientific Corporation; Terumo Corporation; iVascular SLU; Cardinal Health, Inc. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What are the Key Contributors to Growing Demand for Peripheral Stent Implants?
“Increasing Preference among Patients for Outpatient Treatments Due to Their Cost Effectiveness”
Expansion of the peripheral stent implant market size is driven by the growing preference for outpatient treatments over inpatient procedures due to several benefits such as shorter hospital stays, a decreased risk of hospital-acquired infections, and more affordable healthcare. The demand for outpatient operations is rising as more patients look for minimally invasive therapies that offer reduced chances of risks and a minimal period of recovery.
Patients desire outpatient operations, which are more convenient and accessible for them, contributing to market expansion. Also, because outpatient treatments enable more effective resource management, they lessen the strain on hospitals and healthcare providers.
Which Aspects are Restricting Sales Growth of Peripheral Stent Implants?
“High Cost of Manufacturing, Research, and Regulatory Compliance”
Development of new peripheral vascular devices typically requires advanced engineering, sophisticated materials, and high-end technology which leads to the high costs of manufacturing, research, and regulatory compliance. This is driving up the prices of devices. Healthcare organizations find it difficult to finance these devices due to the substantial expenditure required to purchase them, especially for small hospitals or clinics as they have budgets constrained. In the end, it makes it more difficult for them to give patients advanced medical care.
Peripheral stent implants come with various expenses that affect patients, healthcare providers, and institutions in addition to the devices' costs. These expenses cover the price of the anesthesia, surgical facilities, and operating room staff. The complexity of these procedures necessitates specialized equipment and an experienced medical team, which increases the overall costs.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
North America is poised to hold 51.7% of global peripheral stent implant market share in 2024. South Asia & Pacific is also estimated to hold a significant market share and is evaluated to provide ample growth opportunities in the coming years due to rising investments in healthcare infrastructure and the adoption of advanced medical technologies.
Why Do Suppliers See Lucrative Prospects in the United States?
“Well-Developed Healthcare Sector and Technological Advancements in Peripheral Stent Designs”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 1.88 Billion |
| Growth Rate (2024 to 2034) | 5.8% CAGR |
| Projected Value (2034F) | US$ 3.31 Billion |
The field of peripheral artery disease (PAD) treatment is undergoing a revolution in the United States due to technological advancements in drug-eluting, material, and peripheral stent design. These initiatives are helping in enhancements of implants’ safety profiles, longevity, and effectiveness.
Introduction of bioresorbable scaffolds, for example, permits stents to progressively decompose within the body over time, potentially mitigating long-term difficulties linked to permanent implantation. The well-developed healthcare sector is a key factor that is supporting the market for peripheral stent implants in the United States, attracting patients from all over the world to get the best treatment.
- In May 2024, to treat chronic limb-threatening ischemia (CLTI) below the knee, the United States Food and Drug Administration authorized the Esprit BTK everolimus-eluting scaffold system. For the treatment of peripheral artery disease, it is the first drug-eluting resorbable scaffold to be licensed.
Which Peripheral Stent Implant Market Trends are Significant in China?
“Rising Funding for Healthcare Facilities and Availability of Advanced Treatments for PAD”
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 206 Million |
| Growth Rate (2024 to 2034) | 8.3% CAGR |
| Projected Value (2034F) | US$ 457 Million |
China is projected to hold a leading position in 2024 with 54.6% market share in the East Asia region. The increasing funding for modern healthcare facilities and specialized treatment centers helps to improve the availability of advanced treatments for conditions such as peripheral artery disease (PAD). With these ongoing improvements in healthcare facilities, patients are now getting timely diagnoses, evaluations, and treatment, including the option of peripheral stent implants. These advancements are not only satisfying the needs of patients with vascular diseases but also contributing to revenue growth in the market in China.
Category-wise Insights
Based on artery type, the market is segmented into carotid artery stents, fem-pop artery stents, iliac artery stents, and infrapop artery stents. Demand for Iliac artery stents is increasing as they provide minimally invasive solutions for restoring blood flow in the iliac arteries, which are commonly affected by atherosclerosis and stenosis.
Which Peripheral Stent Implant Product is Widely Preferred?
“Low Risk and Long-term Benefits of Drug-Eluting Stents”
| Attribute | Drug-Eluting Stents |
|---|---|
| Segment Value (2024E) | US$ 639.7 Million |
| Growth Rate (2024 to 2034) | 6.9% CAGR |
| Projected Value (2034F) | US$ 1.25 Billion |
Demand for drug-eluting stents (DESs) growing at high space compared to other product types because they outperform bare-metal stents in terms of long-term results and restenosis risk reduction. Drugs that prevent the formation of scar tissue are coated on DES, which lowers the risk that the artery will re-occur after the stent is inserted. Patients who have a high risk of restenosis and those with complicated lesions benefit most from this characteristic.
Technological advancements have also enhanced the delivery and design of DES, increasing its effectiveness and safety. Due to this, drug-eluting stents are becoming a preferred choice for doctors and patients, which is fueling the market for peripheral stent implants.
Why Do Hospitals Generate Significant Revenue for Peripheral Stent Implant Suppliers?
“Availability of Sophisticated Equipment and Wide Range of Interventional Treatments”
| Attribute | Hospitals |
|---|---|
| Segment Value (2024E) | US$ 2.35 Billion |
| Growth Rate (2024 to 2034) | 6.4% CAGR |
| Projected Value (2034F) | US$ 4.38 Billion |
Hospitals are the main facilities where peripheral stent implantation treatments are performed. Hospitals offer a centralized setting and provide a wide range of interventional treatments, including peripheral stent implantation. Hospitals usually have sophisticated equipment, including advanced catheterization labs and skilled medical teams.
Established contacts with producers of medical devices make it easier for hospitals to obtain and use peripheral stent implants. Hospital-based services generally receive a sizable share of government healthcare spending due to reimbursement policies and healthcare financing schemes.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Key players in the peripheral stent implant market are introducing advanced yet budget-friendly products to capture a significant market share by using several market strategies such as collaborations, mergers, and acquisitions.
- In March 2024, the first patient was enrolled in the "AGILITY" investigational device exemption (IDE) study, which aims to evaluate the safety and efficacy of the Becton, Dickinson and Company’s vascular-covered stent for the treatment of peripheral arterial disease (PAD).
- In October 2023, MedAlliance, a Swiss company that develops drug-eluting balloon technology, was acquired by Cordis, a global leader in the research and production of interventional cardiovascular and endovascular technologies.
- In August 2021, Royal Philips announced that it had reached an agreement on acquiring Vesper Medical Inc., a company located in the United States that provides minimally invasive peripheral vascular devices.
- In December 2020, the EFEMORAL I FIH clinical research was the first-in-human (FIH) use of Efemoral Medical's bioresorbable vascular scaffold system (EVSS) with FlexStep Technology. To relieve symptoms and prevent reintervention for this traditionally difficult patient group, the bioresorbable stent is intended to treat a wide variety of patients with peripheral artery disease (PAD).
Fact.MR provides detailed information about the price points of prominent manufacturers of peripheral stent implants positioned across the world, sales growth, production capacity, and speculative technological expansion, in this new market report.
Segmentation of Peripheral Stent Implant Market Research
-
By Product :
- Bare Metal Stents
- Covered Stents
- Drug-Eluting Stents
-
By Artery :
- Carotid Artery Stents
- Fem-Pop Artery Stents
- Iliac Artery Stents
- Infrapop Artery Stents
-
By End User :
- Hospitals
- Ambulatory Surgical Centers/Outpatient
-
By Region :
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 6.1. Artery
- 6.2. Product
- 6.3. End User
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Artery
- 7.1. Carotid Artery Stents
- 7.2. Fem-Pop Artery Stents
- 7.3. Iliac Artery Stents
- 7.4. Infrapop Artery Stents
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Product
- 8.1. Bare Metal Stents
- 8.2. Covered Stents
- 8.3. Drug-Eluting Stents
- 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End User
- 9.1. Hospitals
- 9.2. Ambulatory Surgical Centers/Outpatient
- 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Western Europe
- 10.4. Eastern Europe
- 10.5. East Asia
- 10.6. South Asia & Pacific
- 10.7. Middle East & Africa
- 11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 13. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 14. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 15. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 16. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 17. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 18. Sales Forecast 2024 to 2034 by Artery, Product, End User, and Region for 30 Countries
- 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 20. Company Profile
- 20.1. Biotronik SE & Co. KG
- 20.2. W. L. Gore & Associates Inc.
- 20.3. Abbott Laboratories
- 20.4. Cook Medical, Inc.
- 20.5. B. Braun Melsungen AG
- 20.6. Medtronic Plc.
- 20.7. Terumo Medical
- 20.8. Microport Scientific Corporation
- 20.9. Boston Scientific Corporation
- 20.10. Terumo Corporation
- 20.11. iVascular SLU
- 20.12. Cardinal Health, Inc.
- 21. Assumptions and Acronyms Arteryd
- 22. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Artery, 2019 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Artery, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Artery, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2019 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by Artery, 2019 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by Artery, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Artery, 2024 to 2034
Table 19: North America Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 20: North America Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 28: Latin America Market Value (US$ Mn) Analysis, by Artery, 2019 to 2023
Table 29: Latin America Market Value (US$ Mn) Analysis, by Artery, 2024 to 2034
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Artery, 2024 to 2034
Table 31: Latin America Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 32: Latin America Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 37: Western Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 38: Western Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Western Europe Market Value (US$ Mn) Analysis, by Artery, 2019 to 2023
Table 41: Western Europe Market Value (US$ Mn) Analysis, by Artery, 2024 to 2034
Table 42: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Artery, 2024 to 2034
Table 43: Western Europe Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 44: Western Europe Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 45: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 46: Western Europe Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 47: Western Europe Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 48: Western Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 49: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 50: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 51: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 52: Eastern Europe Market Value (US$ Mn) Analysis, by Artery, 2019 to 2023
Table 53: Eastern Europe Market Value (US$ Mn) Analysis, by Artery, 2024 to 2034
Table 54: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Artery, 2024 to 2034
Table 55: Eastern Europe Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 56: Eastern Europe Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 57: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 58: Eastern Europe Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 59: Eastern Europe Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 60: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 61: East Asia Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 62: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 63: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 64: East Asia Market Value (US$ Mn) Analysis, by Artery, 2019 to 2023
Table 65: East Asia Market Value (US$ Mn) Analysis, by Artery, 2024 to 2034
Table 66: East Asia Market Value (US$ Mn) Opportunity Analysis, by Artery, 2024 to 2034
Table 67: East Asia Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 68: East Asia Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 69: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 70: East Asia Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 71: East Asia Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 72: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 73: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 74: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 75: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 76: South Asia & Pacific Market Value (US$ Mn) Analysis, by Artery, 2019 to 2023
Table 77: South Asia & Pacific Market Value (US$ Mn) Analysis, by Artery, 2024 to 2034
Table 78: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Artery, 2024 to 2034
Table 79: South Asia & Pacific Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 80: South Asia & Pacific Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 81: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 82: South Asia & Pacific Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 83: South Asia & Pacific Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 84: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 85: MEA Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 86: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 87: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 88: MEA Market Value (US$ Mn) Analysis, by Artery, 2019 to 2023
Table 89: MEA Market Value (US$ Mn) Analysis, by Artery, 2024 to 2034
Table 90: MEA Market Value (US$ Mn) Opportunity Analysis, by Artery, 2024 to 2034
Table 91: MEA Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 92: MEA Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 93: MEA Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 94: MEA Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 95: MEA Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 96: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Artery, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Artery, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Artery, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Product, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Product, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by End User, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by End User, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 20: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 21: North America Market Share Analysis by Country, 2024 & 2034
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 24: North America Market Share and BPS Analysis by Artery, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projections by Artery, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by Artery, 2024 to 2034
Figure 27: North America Market Share and BPS Analysis by Product, 2024 & 2034
Figure 28: North America Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 29: North America Market Attractiveness Analysis by Product, 2024 to 2034
Figure 30: North America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 36: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 37: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 39: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 40: Latin America Market Share and BPS Analysis by Artery, 2024 & 2034
Figure 41: Latin America Market Y-o-Y Growth Projections by Artery, 2024 to 2034
Figure 42: Latin America Market Attractiveness Analysis by Artery, 2024 to 2034
Figure 43: Latin America Market Share and BPS Analysis by Product, 2024 & 2034
Figure 44: Latin America Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 45: Latin America Market Attractiveness Analysis by Product, 2024 to 2034
Figure 46: Latin America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 48: Latin America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 49: Western Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 50: Western Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 51: Western Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 52: Western Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 53: Western Europe Market Share Analysis by Country, 2024 & 2034
Figure 54: Western Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 55: Western Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 56: Western Europe Market Share and BPS Analysis by Artery, 2024 & 2034
Figure 57: Western Europe Market Y-o-Y Growth Projections by Artery, 2024 to 2034
Figure 58: Western Europe Market Attractiveness Analysis by Artery, 2024 to 2034
Figure 59: Western Europe Market Share and BPS Analysis by Product, 2024 & 2034
Figure 60: Western Europe Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 61: Western Europe Market Attractiveness Analysis by Product, 2024 to 2034
Figure 62: Western Europe Market Share and BPS Analysis by End User, 2024 & 2034
Figure 63: Western Europe Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 64: Western Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 66: Eastern Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 67: Eastern Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 68: Eastern Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 69: Eastern Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 70: Eastern Europe Market Share Analysis by Country, 2024 & 2034
Figure 71: Eastern Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 72: Eastern Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 73: Eastern Europe Market Share and BPS Analysis by Artery, 2024 & 2034
Figure 74: Eastern Europe Market Y-o-Y Growth Projections by Artery, 2024 to 2034
Figure 75: Eastern Europe Market Attractiveness Analysis by Artery, 2024 to 2034
Figure 76: Eastern Europe Market Share and BPS Analysis by Product, 2024 & 2034
Figure 77: Eastern Europe Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 78: Eastern Europe Market Attractiveness Analysis by Product, 2024 to 2034
Figure 79: Eastern Europe Market Share and BPS Analysis by End User, 2024 & 2034
Figure 80: Eastern Europe Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 81: Eastern Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 82: East Asia Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 83: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 84: East Asia Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 85: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 86: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 87: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 88: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 89: East Asia Market Share and BPS Analysis by Artery, 2024 & 2034
Figure 90: East Asia Market Y-o-Y Growth Projections by Artery, 2024 to 2034
Figure 91: East Asia Market Attractiveness Analysis by Artery, 2024 to 2034
Figure 92: East Asia Market Share and BPS Analysis by Product, 2024 & 2034
Figure 93: East Asia Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 94: East Asia Market Attractiveness Analysis by Product, 2024 to 2034
Figure 95: East Asia Market Share and BPS Analysis by End User, 2024 & 2034
Figure 96: East Asia Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 97: East Asia Market Attractiveness Analysis by End User, 2024 to 2034
Figure 98: South Asia & Pacific Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 99: South Asia & Pacific Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 100: South Asia & Pacific Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 101: South Asia & Pacific Market Incremental $ Opportunity, 2024 to 2034
Figure 102: South Asia & Pacific Market Share Analysis by Country, 2024 & 2034
Figure 103: South Asia & Pacific Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 104: South Asia & Pacific Market Attractiveness Analysis by Country, 2024 to 2034
Figure 105: South Asia & Pacific Market Share and BPS Analysis by Artery, 2024 & 2034
Figure 106: South Asia & Pacific Market Y-o-Y Growth Projections by Artery, 2024 to 2034
Figure 107: South Asia & Pacific Market Attractiveness Analysis by Artery, 2024 to 2034
Figure 108: South Asia & Pacific Market Share and BPS Analysis by Product, 2024 & 2034
Figure 109: South Asia & Pacific Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 110: South Asia & Pacific Market Attractiveness Analysis by Product, 2024 to 2034
Figure 111: South Asia & Pacific Market Share and BPS Analysis by End User, 2024 & 2034
Figure 112: South Asia & Pacific Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 113: South Asia & Pacific Market Attractiveness Analysis by End User, 2024 to 2034
Figure 114: MEA Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 115: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 116: MEA Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 117: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 118: MEA Market Share Analysis by Country, 2024 & 2034
Figure 119: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 120: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 121: MEA Market Share and BPS Analysis by Artery, 2024 & 2034
Figure 122: MEA Market Y-o-Y Growth Projections by Artery, 2024 to 2034
Figure 123: MEA Market Attractiveness Analysis by Artery, 2024 to 2034
Figure 124: MEA Market Share and BPS Analysis by Product, 2024 & 2034
Figure 125: MEA Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 126: MEA Market Attractiveness Analysis by Product, 2024 to 2034
Figure 127: MEA Market Share and BPS Analysis by End User, 2024 & 2034
Figure 128: MEA Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 129: MEA Market Attractiveness Analysis by End User, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the peripheral stent implant market?
The worldwide market for peripheral stent implants is estimated at US$ 4.11 billion in 2024.
What is the market projection for peripheral stent implants for 2034?
The peripheral stent implant market is forecasted to reach US$ 7.76 billion by 2034-end.
How fast is the market for peripheral stent implants expanding?
The market is projected to expand at a CAGR of 6.6% between 2024 to 2034.
Who are the top peripheral stent implant companies?
Key market players are Biotronik SE & Co. KG, W. L. Gore & Associates Inc., Abbott Laboratories, and Cook Medical, Inc.
At what pace is the market expected to grow in Japan?
The market in Japan is projected to expand at a CAGR of 7.7% through 2034.
What are the projected sales of bare metal stents?
Bare metal stent sales are projected to register 6.5% CAGR and reach US$ 5.88 billion by 2034.
What is the estimated revenue from hospitals in this market?
Based on end user, hospitals are projected to generate revenue worth US$ 4.38 billion by 2034.
Which region is projected to hold a high market share?
The North American region is projected to lead in 2024 with 51.7% market share.
Peripheral Stent Implant Market